Christopher Reyes is a biophysicist turned serial biotech entrepreneur and the CEO, co-founder, and director of Bloom Science, a San Diego company developing living medicines that harness the gut-brain axis. Bloom's lead program, BL-001, is a first-in-class oral live biotherapeutic designed to replicate the anti-seizure effects of the ketogenic diet, built on technology licensed from UCLA. With a PhD in biophysics from UCSF and a track record that includes a fast-acquired cancer startup, Reyes is betting that genetically optimized gut bacteria can treat pharmacoresistant neurological diseases.
Noel Goddard is the CEO of Qunnect, a Brooklyn-based quantum networking company building hardware that turns ordinary telecom fiber into quantum-secure networks - at room temperature, no exotic cooling required. A biophysicist with a Rockefeller PhD and a Harvard fellowship, she taught physics at Hunter College, founded two biotech startups, and worked as a deep-tech seed investor before joining Qunnect in 2020 as COO and then CEO. Under her, Qunnect commercialized the world's first room-temperature quantum memory, ran a 34km entanglement link over live New York City fiber, and raised an oversubscribed Series A led by Airbus Ventures.